Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
The messenger ribonucleic acid (mRNA) synthesis and manufacturing market has experienced rapid expansion in recent years. It is projected to increase from $4.56 billion in 2024 to $5.14 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.7%. The market’s historical growth can be attributed to various factors, including heightened government funding for pandemic preparedness, the early effectiveness of COVID-19 mRNA vaccines, a rising interest in personalized medicine, an increase in the incidence of infectious diseases, and strategic partnerships between biotech firms and academia.
The messenger ribonucleic acid (mRNA) synthesis and manufacturing market is projected to experience substantial expansion over the coming years, reaching $8.21 billion by 2029 with a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is fueled by several factors, including the broadening of therapeutic applications beyond vaccines, innovations in mRNA delivery technologies, greater investment in biomanufacturing facilities, increasing need for swift vaccine development solutions, and backing from regulatory bodies for quicker approvals. Significant developments anticipated during this period encompass a move towards distributed and modular mRNA production facilities, the incorporation of artificial intelligence and automation into synthesis processes, the creation of temperature-stable mRNA formulations, the emergence of circRNA technology, and the advent of self-amplifying mRNA platforms.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25832&type=smp
Which Factors And Drivers Are Influencing The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market In 2025?
The rising occurrence of infectious diseases is projected to drive the expansion of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in the future. These diseases are defined as conditions resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, encompassing illnesses such as malaria, which can be transmitted through direct or indirect contact. The growing spread of infectious diseases stems from rapid urbanization, contributing to greater population density and close human interaction, thus accelerating the transmission of infections. Messenger ribonucleic acid (mRNA) synthesis and manufacturing aids in combating infectious diseases by facilitating the swift creation and large-scale manufacturing of specific vaccines and therapeutic agents designed to elicit a particular immune response. For example, in November 2023, data from the World Health Organization, a Switzerland-based intergovernmental organization, indicated that in 2022, there were approximately 249 million malaria (an infectious disease) cases worldwide, marking an increase of 5 million cases (2%) over the figures from 2021. Consequently, the expanding occurrence of infectious diseases is fueling the growth of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market.
What Are The Key Segments In The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
The messenger ribonucleic acid (mrna) synthesis and manufacturing market covered in this report is segmented –
1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis
2) By Scale Of Operation: Preclinical, Clinical, Commercial
3) By Therapeutic Area: Infectious Diseases, Oncology, Other Therapeutic Areas
4) By Application: Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications
Subsegments:
1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services
2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services
Which Key Trends Are Expected To Influence The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market In The Coming Years?
Leading entities within the messenger ribonucleic acid (mRNA) synthesis and manufacturing market are prioritizing the creation of advanced solutions, like co-transcriptional capping platforms, to expedite preclinical studies and ease regulatory compliance. Such a platform represents a unique technique for effectively adding a protective cap to messenger ribonucleic acid (mRNA) molecules during their creation, thereby improving mRNA stability, the efficiency of translation, and control over immunogenicity. An example of this trend is GenScript, a US-based life sciences research tools company, which introduced its good manufacturing practice (GMP)-like messenger ribonucleic acid (mRNA) manufacturing service in May 2025. This particular service offers scalable, regulatory-conscious production of high-purity, functional mRNA suitable for investigational new drug (IND)-supporting preclinical investigations, encompassing toxicology, biodistribution, and pharmacokinetics or pharmacodynamics (PK or PD) evaluations. Operating within cleanroom-compliant, International Organization for Standardization (ISO) 7-classified environments, it integrates patented co-transcriptional capping technology. Tailored mRNA can be provided through this service in a timeframe as brief as seven weeks. This advancement effectively closes the significant development gap between research-grade and full good manufacturing practice (GMP) production, allowing emerging biotechnology and pharmaceutical firms to conduct studies that meet regulatory standards without incurring the substantial expenses and time delays associated with conventional good manufacturing practice (GMP) methods.
Who Are The Prominent Global Companies Shaping The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC
Download The Full Report For Exclusive Market Findings:
How Does The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Perform Across Key Geographic Regions?
North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25832&type=smp
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market 2025, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Global Market Report 2025
Gene Synthesis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Mrna Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model